Cargando…

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

Myeloid neoplasms (MN) with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic MN. Therefore, routine analysis of gene panels by next‐generation sequencing provides an effective approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrés‐Zayas, Cristina, Suárez‐González, Julia, Rodríguez‐Macías, Gabriela, Dorado, Nieves, Osorio, Santiago, Font, Patricia, Carbonell, Diego, Chicano, María, Muñiz, Paula, Bastos, Mariana, Kwon, Mi, Díez‐Martín, José Luis, Buño, Ismael, Martínez‐Laperche, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410541/ https://www.ncbi.nlm.nih.gov/pubmed/33533142 http://dx.doi.org/10.1002/1878-0261.12921

Ejemplares similares

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations
por: Chicano, María, et al.
Publicado: (2021)

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
por: Carbonell, Diego, et al.
Publicado: (2019)

Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
por: Andrés-Zayas, Cristina, et al.
Publicado: (2023)

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma
por: Bastos-Oreiro, Mariana, et al.
Publicado: (2021)

Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation
por: Suárez-González, Julia, et al.
Publicado: (2020)

Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021)

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
por: Muñiz, Paula, et al.
Publicado: (2021)

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
por: Muñiz, Paula, et al.
Publicado: (2022)

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
por: Solán, Laura, et al.
Publicado: (2021)

ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
por: Solán, Laura, et al.
Publicado: (2019)

Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017)

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
por: Vallejo, Miren, et al.
Publicado: (2022)

FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
por: Carbonell, Diego, et al.
Publicado: (2022)

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application
por: Navarro-Bailón, Almudena, et al.
Publicado: (2020)

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
por: Gargallo, Pablo, et al.
Publicado: (2021)

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
por: Baliakas, Panagiotis, et al.
Publicado: (2019)

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
por: Martínez-Laperche, C., et al.
Publicado: (2022)

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
por: Martínez-Laperche, C., et al.
Publicado: (2022)

Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
por: Fabiani, Emiliano, et al.
Publicado: (2023)

P1427: MONITORING CAR-T CELL IN B-CELL LYMPHOMA PATIENTS THROUGH SINGLE CHAIN VARIABLE FRAGMENT BY DIGITAL PCR
por: De La Iglesia San Sebastián, I., et al.
Publicado: (2022)

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
por: Bannon, Sarah A., et al.
Publicado: (2021)

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

Germline predisposition to genitourinary rhabdomyosarcoma
por: Schneider, Kami Wolfe, et al.
Publicado: (2020)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

P1423: CIRCULATING CELL-FREE DNA KINETICS MEASURED BY DIGITAL PCR IN LYMPHOMA PATIENTS UNDERGOING CD19-CAR-T THERAPY
por: López-Esteban, M., et al.
Publicado: (2022)

Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia
por: Kim, Borahm, et al.
Publicado: (2020)

PB2161: CHARACTERISTICS OF AGGRESSIVE B-CELL LYMPHOMAS WITH MYC REARRANGEMENT
por: Ortuzar Pasalodos, A., et al.
Publicado: (2022)

New progress in the study of germline susceptibility genes of myeloid neoplasms
por: Bi, Lei, et al.
Publicado: (2021)

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity
por: Molteni, Elisabetta, et al.
Publicado: (2023)

Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia
por: Ramos, Harry, et al.
Publicado: (2022)

Germline Structural Variations in Cancer Predisposition Genes
por: Pócza, Tímea, et al.
Publicado: (2021)

Diabetes predisposition inherited through maternal germline
por: Zhu, Hong, et al.
Publicado: (2022)

Germline POT1 Variants Can Predispose to Myeloid and Lymphoid Neoplasms
por: Lim, Tristan L., et al.
Publicado: (2021)

Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Novel biallelic variant in BBS9 causative of Bardet–Biedl syndrome: expanding the spectrum of disease-causing genetic alterations
por: Suárez-González, Julia, et al.
Publicado: (2021)

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
por: Mir, Muhammad A, et al.
Publicado: (2015)

Germline polymorphisms of circadian genes and gastric cancer predisposition
por: Rajendran, Senthilkumar, et al.
Publicado: (2020)

Germline MBD4 Mutations and Predisposition to Uveal Melanoma
por: Derrien, Anne-Céline, et al.
Publicado: (2020)

Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
por: Chan, Sock Hoai, et al.
Publicado: (2017)

Heterozygous APC germline mutations impart predisposition to colorectal cancer
por: Preisler, Livia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pafma2tmp18l84igqpn9guumdp